Unlock this StockReport nowClick to Unlock

Alliance Pharma Share Price

APH 67.13p 0.9  1.4%
1:34pm 20.0k
StockRank

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 TTM 2018E 2019E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 20th Dec, paid: 10th Jan more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +15.0%

FINANCIAL BRIEF: For the six months ended 30 June 2018, Alliance Pharma plc revenues increased 10% to £54.5M. Net income decreased 34% to £8.8M. Revenues reflect International segment increase of 32% to £16.5M. Net income was offset by Exceptional compensation income decrease from £5M (income) to £0K, Administration and marketing expenses - increase of 23% to £18.6M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from £0.03 to £0.02. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
A-
A-
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 30th Jun '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2018
31st Dec 2019

Price Target: 1.16
(+75.21% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
3 brokers Broker Consensus Trend
Broker Recommendations for Alliance Pharma
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 0 0 2

Named Brokers and Analysts
Investec Bank (UK) Plc Andrew Whitney , Hardman & Company Martin Hall , Numis Securities Sally Taylor , FinnCap Mark Brewer ,

Profile Summary

Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.

Directors: Peter Butterfield (CEO) , Andrew Franklin (FID) , Janice Timberlake (DHR) , Margaret Boulton (OTH) , Stephen Kidner (OTH) , Dan Thomas (OTH) , Sarah Robinson (SEC) , David Cook (NEC) 51, John Dawson (NED) , Nigel Clifford (NID) , Jo Couilliard (NID) , Richard Jones (NID) 51,

No. of Employees: 182 No. of Shareholders: n/a


Last Annual December 31st, 2017
Last Interim June 30th, 2018
Incorporated June 26, 2001
Public Since November 22, 2001
Shares in Issue 518,230,255
Free Float 463.8m (89.5%)
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Aim All Share , FTSE Aim 100 , FTSE Intl-aim UK 50 ,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

APH Share Price Performance APH Share Price Quote
67.13p
0.9  1.4%
Traded 1:34pm · Minimum 15 min delayed · NMS: 20.0k

Latest APH News Announcements (delayed)

Upcoming APH Events

Recent ↓
Thursday 20th December, 2018
Dividend For ALAPH.L
Wednesday 19th September, 2018
Half Year 2018 Alliance Pharma PLC Earnings Call
Thursday 14th June, 2018
Dividend For ALAPH.L
Thursday 24th May, 2018
Alliance Pharma PLC Annual Shareholders Meeting
Tuesday 27th March, 2018
Full Year 2017 Alliance Pharma PLC Earnings Call
Thursday 21st December, 2017
Dividend For APH
Wednesday 13th September, 2017
Half Year 2017 Alliance Pharma PLC Earnings Call
Wednesday 13th September, 2017
Half Year 2017 Alliance Pharma PLC Earnings Release
Tuesday 18th July, 2017
Q2 2017 Alliance Pharma PLC Pre-Close Trading Update
Thursday 15th June, 2017
Dividend For APH.L
Thursday 25th May, 2017
Alliance Pharma PLC Annual Shareholders Meeting
Friday 7th April, 2017
Half Year 2017 Alliance Pharma PLC Earnings Release
Wednesday 29th March, 2017
Full Year 2016 Alliance Pharma PLC Earnings Release
Thursday 22nd December, 2016
Dividend For APH.L
Wednesday 14th September, 2016
Half Year 2016 Alliance Pharma PLC Earnings Call
Wednesday 14th September, 2016
Half Year 2016 Alliance Pharma PLC Earnings Release
Thursday 16th June, 2016
Dividend For APH.L
Wednesday 25th May, 2016
Alliance Pharma PLC Annual Shareholders Meeting
Thursday 7th April, 2016
Full Year 2015 Alliance Pharma PLC Earnings Presentation
Thursday 7th April, 2016
Full Year 2015 Alliance Pharma PLC Earnings Release


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.


Should you buy APH

Access APH Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis